跳至主要内容
临床试验/NCT01281397
NCT01281397终止不适用

Bleeding Prediction in Patients Undergoing Cardiac Surgery Using Whole Blood Impedance Aggregometry and Rotational Thromboelastometry

University of Zagreb1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
148
试验地点
1
主要终点
Chest tube output in first 24 hours

研究概览

简要总结

Use of whole blood impedance aggregometry and rotational thromboelastometry can reveal useful data about platelet function and viscoelastic properties of blood clot in patients undergoing cardiac surgery.

The purpose of this study is to clarify whether it is possible to predict patients on excessive risk of perioperative bleeding using whole blood impedance aggregometry and rotational thromoelastometry.

Antiplatelet therapy is the cornerstone in treatment of patients with coronary artery disease. Another research goal is to determine the degree of response to antiplatelet therapy before and after surgery and to investigate whether patients by level of response to antiplatelet therapy before surgery have a higher risk of perioperative bleeding.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • > 18 years old
  • Elective cardiac surgery patients
  • Coronary artery disease
  • Aortic valve disease
  • Mitral valve disease
  • Ascendent aorta aneurysm
  • Combine coronary and valve disease
  • Cardiac surgery procedures using cardiopulmonary bypass

排除标准

  • Missing consent
  • Patients with emergent cardiac surgical procedures
  • Patients on antiplatelet therapy other than aspirin or clopidogrel
  • Patients with inaccurate antiplatelet therapy administration documentation
  • Missing data
  • Off-pump procedures
  • Patients younger than 18 years old
  • Patients with severe mental disorders
  • Intrinsic coagulopathy

结局指标

主要结局

Chest tube output in first 24 hours

时间窗: 24 hours after surgical procedure

次要结局

  • Allogenic blood products transfusion(7 days after surgery including the day of surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Petricevic Mate

Mate Petricevic M.D. , Ph.D.

University of Zagreb

研究点 (1)

Loading locations...

相似试验